These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10708292)

  • 1. Long-term effects of therapeutic vaccination with rgp 120.
    Lindenburg K; Langendam MW; Veenstra J; Miedema F; Coutinho R
    AIDS; 2000 Jan; 14(2):203-4. PubMed ID: 10708292
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant glycoprotein vaccines for human immunodeficiency virus-infected children and their effects on viral quasispecies.
    Essajee SM; Yogev R; Pollack H; Greenhouse B; Krasinski K; Borkowsky W
    Clin Diagn Lab Immunol; 2002 Jan; 9(1):79-82. PubMed ID: 11777833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immune responses in asymptomatic human immunodeficiency virus type 1 (HIV-1) infection and effects of vaccination with recombinant envelope glycoprotein of HIV-1.
    Gorse GJ; Simionescu RE; Patel GB
    Clin Vaccine Immunol; 2006 Jan; 13(1):26-32. PubMed ID: 16425996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.
    Birx DL; Loomis-Price LD; Aronson N; Brundage J; Davis C; Deyton L; Garner R; Gordin F; Henry D; Holloway W; Kerkering T; Luskin-Hawk R; McNeil J; Michael N; Foster Pierce P; Poretz D; Ratto-Kim S; Renzullo P; Ruiz N; Sitz K; Smith G; Tacket C; Thompson M; Tramont E; Yangco B; Yarrish R; Redfield RR
    J Infect Dis; 2000 Mar; 181(3):881-9. PubMed ID: 10720508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines and immunology. Overview.
    Laurence J
    AIDS; 1988; 2 Suppl 1():S91-4. PubMed ID: 2852505
    [No Abstract]   [Full Text] [Related]  

  • 6. Research indicates rgp 160 provides long-term immunologic protection. Chimpanzee resists HIV challenge more than two years after vaccination.
    Crit Care Nurse; 1991 Sep; 11(8):1. PubMed ID: 1893756
    [No Abstract]   [Full Text] [Related]  

  • 7. Positive response. Encouraging results in the search for an AIDS vaccine.
    Beardsley T
    Sci Am; 1991 Aug; 265(2):26. PubMed ID: 1862329
    [No Abstract]   [Full Text] [Related]  

  • 8. A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDA.
    Pialoux G; Excler JL; Rivière Y; Gonzalez-Canali G; Feuillie V; Coulaud P; Gluckman JC; Matthews TJ; Meignier B; Kieny MP
    AIDS Res Hum Retroviruses; 1995 Mar; 11(3):373-81. PubMed ID: 7598771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on HIV vaccines.
    Meldorf M; Corey L
    STEP Perspect; 1997; 9(2):5-6, 8-9. PubMed ID: 11364929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human trials of AIDS vaccines: current status and future directions.
    Koff WC; Fauci AS
    AIDS; 1989; 3 Suppl 1():S125-9. PubMed ID: 2558684
    [No Abstract]   [Full Text] [Related]  

  • 11. Human trials of experimental AIDS vaccines: recombinant envelope proteins.
    Snart RS
    AIDS; 1988; 2 Suppl 1():S107-11. PubMed ID: 2906544
    [No Abstract]   [Full Text] [Related]  

  • 12. [Optimism about a vaccine against HIV. Strong immune response obtained by the Swedish technic. Interview by Bo Lennholm].
    Morein B
    Lakartidningen; 1988 Jun; 85(23):2090-2. PubMed ID: 3386341
    [No Abstract]   [Full Text] [Related]  

  • 13. [A potential AIDS vaccine tester].
    Fortschr Med; 1988 Jul; 106(22):14-5. PubMed ID: 2851511
    [No Abstract]   [Full Text] [Related]  

  • 14. Active immunization of patients with HIV infection: a study of the effect of VaxSyn, a recombinant HIV envelope subunit vaccine, on progression of immunodeficiency.
    Tsoukas CM; Raboud J; Bernard NF; Montaner JS; Gill MJ; Rachlis A; Fong IW; Schlech W; Djurdjev O; Freedman J; Thomas R; Lafrenière R; Wainberg MA; Cassol S; O'Shaughnessy M; Todd J; Volvovitz F; Smith GE
    AIDS Res Hum Retroviruses; 1998 Apr; 14(6):483-90. PubMed ID: 9566550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocktail vaccine may protect against HIV.
    Gee CF
    Nursing (Lond); 1990 Jul 12-25; 4(14):8. PubMed ID: 2381586
    [No Abstract]   [Full Text] [Related]  

  • 16. Will chimps come up trumps in HIV war?
    Gee CF
    Nursing (Lond); 1990 Jun 28-Jul 11; 4(13):7. PubMed ID: 2115986
    [No Abstract]   [Full Text] [Related]  

  • 17. Rabies experiment.
    Koprowski H; Celis E; Curtis P; Dietzschold B; Rupprecht C; Tollis M; Wunner W
    Nature; 1987 Apr 16-22; 326(6114):636. PubMed ID: 3561504
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV-1MN recombinant gp120 vaccine serum, which fails to neutralize primary isolates of HIV-1, does not antagonize neutralization by antibodies from infected individuals.
    Wrin T; Nunberg JH
    AIDS; 1994 Nov; 8(11):1622-3. PubMed ID: 7848602
    [No Abstract]   [Full Text] [Related]  

  • 19. [Progression of viral infection in twins born from a mother infected with human immunodeficiency virus].
    Gaggero A; Escanilla D; Larrañaga C; Uribe P; Espejo R
    Rev Med Chil; 1995 Oct; 123(10):1189-98. PubMed ID: 8733309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The true cost of a free AIDS vaccine.
    Science; 1993 Aug; 261(5125):1107. PubMed ID: 8356442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.